| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.945 | 23.689 | 21.518 | 23.667 | 23.614 | 29.162 | 20.560 | 18.806 | 18.435 | 24.834 |
| Total Income - EUR | 21.945 | 23.690 | 21.518 | 23.667 | 23.614 | 29.162 | 20.819 | 19.820 | 18.435 | 24.836 |
| Total Expenses - EUR | 20.344 | 24.651 | 20.430 | 19.268 | 18.866 | 27.374 | 21.668 | 20.217 | 19.413 | 28.697 |
| Gross Profit/Loss - EUR | 1.601 | -960 | 1.089 | 4.399 | 4.748 | 1.789 | -849 | -397 | -979 | -3.861 |
| Net Profit/Loss - EUR | 943 | -1.671 | 443 | 3.688 | 4.041 | 981 | -1.474 | -992 | -979 | -3.861 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Acvila Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 96 | 95 | 115 | 111 | 1.396 | 6.109 | 3.978 | 3.148 | 945 | 300 |
| Current Assets | 13.027 | 11.486 | 14.236 | 16.194 | 17.542 | 14.787 | 12.579 | 10.530 | 9.328 | 6.235 |
| Inventories | 5.228 | 5.330 | 8.815 | 10.395 | 12.144 | 12.764 | 10.615 | 9.087 | 8.412 | 2.199 |
| Receivables | 7.655 | 6.064 | 5.341 | 5.713 | 4.888 | 1.270 | 1.596 | 1.215 | 566 | 937 |
| Cash | 143 | 92 | 80 | 86 | 509 | 753 | 369 | 228 | 350 | 3.099 |
| Shareholders Funds | -16.528 | -18.030 | -17.282 | -13.277 | -8.978 | -7.827 | -9.128 | -10.148 | -11.096 | -14.895 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 29.701 | 29.662 | 31.695 | 29.643 | 27.976 | 28.796 | 25.974 | 23.979 | 21.778 | 22.030 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Acvila Intermed S.r.l.